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Assessing a new Cytotoxicity Test for Material
Characterization of Single-Use Products
Alexander Tappe, Elke Jurkiewicz
Sartorius Stedim Biotech GmbH, D-37079 Göttingen, Germany
BACKGROUND
In recent years, reduction of mammalian cell growth in single-use (SU) bioreactors and Erlenmeyer shake flasks have been observed, despite the fact that these bioreactors and the respective raw materials to manufacture those SU containers have
been extensively tested according to existing cytotoxicity standards (e.g. USP<87> and DIN ISO 10993-5). For example, bis(2,4-di-tert-butylphenyl)phosphate (bDtBPP) has been identified in irradiated bioreactor film extracts by Hammond et al. and its
cytotoxicity has been correlated to cell growth reduction [1, 2]. This enabled suppliers to adjust their manufacturing process and increase the performance of the films, in the case of Sartorius the performance of the new Flexsafe® film [3].
While impact of bDtBPP was resolved, the question still remains how this could have been missed and how suppliers can ensure that such incidents will not occur in the future again. To gain a better understanding of the necessary criteria for a
suitable cell growth standard in biopharma applications we compared the influence of three known cytotoxins on the growth of both L-929 cells, a cell line which is recommended in the USP<87>, and a suspension CHO-DG44 cell line. Assuming
suppliers of raw material, in particular resins suppliers, have good control on the main ingredients, a suitable growth test would need to identify impacts of minuscule amounts of cytotoxins.

EXPERIMENTAL APPROACH
Cell based assay

Cytotoxins

Two cell lines were used to compare the effect of the cytotoxins: the adherent L-929
cell line as recommended in the USP <87>, and a suspension CHO clone (Cellca, D).
Cells were expanded for one passage before transferring them into multi-well plates
(MWP). The cytotoxins where dissolved either in DMSO or in phosphate buffer based on
their dissolubility and added to the medium as a single addition.
Cells were grown for 1 or 3 days, respectively and afterwards counted with the
NucleoCounter (CHO) or used for an XTT-Test (L-929). Culture conditions are listed in
Table 1 for pre-cultivation and Table 2 for the cytotoxicity.

In this study, three cytotoxins with different modes of cell interactions where used.
Mitomycin C (Fig. 1) inhibits DNA synthesis. It reacts
covalently with DNA, in vivo and in vitro, forming
crosslinks between the complementary strands
of DNA. This prevents the separation of the
complementary DNA strands, thus inhibiting
DNA replication.

Figure 1. Structure of Mitomycin C

Table 1. Pre-culture conditions

Cycloheximide (Fig. 2) binds to the ribosome and
blocks translational elongation, thus
inhibiting protein biosynthesis of the cells.

Table 2. Test conditions

Table 1: Pre-Culture Parameters
Figure 2. Structure of Cycloheximide

bis(2,4-di-tert-butylphenyl)phosphate (bDtBPP,
Fig. 3) induces a decrease of the mitochondrial
membrane potential of CHO cells.
Figure 3. Structure of bDtBPP

RESULTS AND DISCUSSION
Sensitivity to bDtBPP

Sensitivity to Cycloheximide

Sensitivity to Mitomycin C

Impact of serum on cytotoxicity

The sensitivity of CHO-DG44 growth test to
bDtBPP was compared to the L-929 test
sensitivity (Fig. 4). Due to the dissolubility,
bDtBPP was dissolved in DMSO, followed by a
dilution in cell culture medium.
CHO cell growth was significantly impacted at
concentrations >0.21 mg/L, and was reduced to
21% normalized growth (compared to the
reference) at 0.42 mg/L. According to this results
an EC50 concentration of approx. 0.3 mg/L was
determined for CHO-DG44.
However, L-929 cell growth was only moderately
affected by 0.21 – 3.36 mg/L bDtBPP. While it
requires more data to calculate the EC50 it is
obvious that it is higher than 16.8 mg/L. Separate
cytotoxicity tests with DMSO confirmed that the
solvent does not impact the bDtBPP test under
these conditions (data not shown).

Again, DMSO is required as solvent for
Cycloheximide. Cell proliferation of both cell lines
is strongly dose-dependent (Fig. 5). In the presence
of 1 mg/L L-929 cell growth was reduced to 60%
compared to the reference. For concentrations
above 1 mg/L the cell growth-interfering influence
of DMSO has to be examined in more detail, e.g. by
interference tests. Thus, the EC50 could not be
calculated from the available data.

As opposed to the bDtBPP and Cycloheximide,
Mitomycin C is highly soluble in water and was
dissolved in PBS buffer. Therefore, an influence
of a solvent can be ruled out for this test.

Due to the different cell line specific toxin
sensitivity the impact of the test conditions need to
be assessed. One major difference is the use of a
chemically defined medium for the CHO cells and
the use of a serum-containing medium for the L929 cells. Serum albumin is known for its
extraordinary ligand binding capacity [4].
Therefore, we assessed the impact of serum on the
CHO test with bDtBPP in the absence and presence
of different serum concentrations (Fig. 7). The
result clearly show that the cytotoxic effect of
bDtBPP can be masked at least up to 0.84 mg/L. It
is likely that the outcome of the cytotoxicity test
with the recommended L-929 test is dominated by
the ligand binding capacity of serum as well.

Figure 4. Dose dependency of bDtBPP-cytotoxicity on CHO-DG44
and L-929 cell growth.

In contrast, the proliferation of the CHO-DG44 cell
line was impacted more strongly by Cycloheximide
with an EC50 of approx. 0.07 mg/L. At this
concentrations DMSO does not impact the
cytotoxicity test on Cycloheximide (data not
shown).

Figure 5. Dose dependency of Cycloheximide-cytotoxicity on
CHO DG44 and L-929 cell growth.

As shown with bDtBPP, Mitomycin C (Fig. 6) was
more toxic to CHO-DG44 than to L-929 cells.
With an EC50 of 0.05 mg/L Mitomycin C is the
strongest cytotoxin of the three toxins assessed.
For the L-929 cells the EC50 is approx. 29 mg/L.
Until now there is no data available on the other
toxin to conclude which of the three toxins is
most toxic for the L-929 cells.

Figure 6. Dose dependency of Mitomycin C-cytotoxicity on CHODG44 and L-929 cell growth.

Figure 7. Effect of FBS on the cytotoxicity of bDtBPP during the cell
growth test.

CONCLUSION
All three cytotoxins showed increased cytotoxicities for CHO cells compared to L-929 cells. CHO cells seem to be more suitable for testing of raw materials for biopharma processes.
These results indicate that serum albumin is impacting the test outcome of the cytotoxicity tests by its extraordinary ligand binding capacity. For a more detailed analysis it would be
helpful to harmonize both growth tests in equipment involved. Further trials should focus on additional process parameters, in particular cultivation time.
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